{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:31:56Z","timestamp":1773048716777,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijbiomac.2024.135890","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T15:37:14Z","timestamp":1726933034000},"page":"135890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P3","title":["Exploration of 1,3,5-trisubstituted pyrazoline derivatives as human carbonic anhydrase inhibitors: Synthesis, biological evaluation and in silico studies"],"prefix":"10.1016","volume":"280","author":[{"given":"Danaboina","family":"Srikanth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kollu","family":"Shanthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niccol\u00f2","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swanand Vinayak","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahammad Ghouse","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manasa","family":"Vadakattu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Madhavi","family":"Yaddanapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.135890_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129411","article-title":"A simple yet multifaceted 90 years old, evergreen enzyme: carbonic anhydrase, its inhibition and activation","volume":"93","author":"Supuran","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200019","article-title":"Design, synthesis, SAR, and biological evaluation of saccharin-based hybrids as carbonic anhydrase inhibitors, Archiv Der","volume":"355","author":"Chinchilli","year":"2022","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0015","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0020","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2185760","article-title":"Synthesis and biological evaluation of new 3-substituted coumarin derivatives as selective inhibitors of human carbonic anhydrase IX and XII","volume":"38","author":"Mahammad Ghouse","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/metabo11040225","article-title":"Synthesis and biological evaluation of coumarin-linked 4-anilinomethyl-1,2,3-triazoles as potent inhibitors of carbonic anhydrases IX and XIII involved in tumorigenesis","volume":"11","author":"Thacker","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300316","article-title":"6-Aminocoumarin oxime-ether\/sulfonamides as selective hCA IX and XII inhibitors: synthesis, evaluation, and molecular dynamics studies","volume":"356","author":"Ghouse","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0040","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/cmdc.202000915","article-title":"Coumarin-thiourea hybrids show potent carbonic anhydrase IX and XIII inhibitory action","volume":"16","author":"Thacker","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1215\/S1152851705000025","article-title":"Expression of hypoxia-inducible carbonic anhydrases in brain tumors","volume":"7","author":"Proescholdt","year":"2005","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0046-8177(96)90062-3","article-title":"Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia","volume":"27","author":"Resnick","year":"1996","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1215\/15228517-2007-065","article-title":"Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas","volume":"10","author":"Haapasalo","year":"2008","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0060","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1073\/pnas.95.13.7608","article-title":"Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers","volume":"95","author":"T\u00fcreci","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0065","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3390\/cancers14143297","article-title":"Cancer therapeutic targeting of hypoxia induced carbonic anhydrase IX: from bench to bedside","volume":"14","author":"McDonald","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0070","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0075","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jm501798g","article-title":"Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site","volume":"58","author":"Tanpure","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/0250-474X.40344","article-title":"Novel 2-pyrazoline derivatives as potential antibacterial and antifungal agents","volume":"70","author":"Kini","year":"2008","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0090","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.bmcl.2004.03.072","article-title":"Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor","volume":"14","author":"Jeong","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0095","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1016\/j.bmcl.2004.06.046","article-title":"Synthesis and DP-IV inhibition of cyano-pyrazoline derivatives as potent anti-diabetic agents","volume":"14","author":"Ahn","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0100","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.bmcl.2007.12.043","article-title":"Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents","volume":"18","author":"Amir","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0105","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1080\/13880200902946452","article-title":"Synthesis and screening of anti-cancer, antioxidant, and anti-inflammatory activities of novel galloyl pyrazoline derivatives","volume":"47","author":"Abdel-Aziz","year":"2009","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/14756360701265832","article-title":"Synthesis of 5-(4-hydroxy-3-methylphenyl)-5-(substituted phenyl)-4, 5-dihydro-1H-1-pyrazolyl-4-pyridylmethanone derivatives with anti-viral activity","volume":"22","author":"Ali","year":"2007","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejmech.2006.08.004","article-title":"Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives","volume":"42","author":"Ali","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0120","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.bmcl.2004.03.079","article-title":"Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors","volume":"14","author":"Jeong","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0125","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/molecules25051047","article-title":"Antimicrobial, antioxidant, and anticancer activities of some novel Isoxazole ring containing chalcone and dihydropyrazole derivatives","volume":"25","author":"Shaik","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0130","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/molecules25143188","article-title":"Design, facile synthesis and characterization of dichloro substituted chalcones and dihydropyrazole derivatives for their antifungal, antitubercular and antiproliferative activities","volume":"25","author":"Shaik","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0135","first-page":"310","article-title":"Synthesis","volume":"19","author":"Lokesh","year":"2019","journal-title":"biological evaluation and molecular docking studies of new pyrazolines as an antitubercular and cytotoxic agents, IDDT"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0140","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.bmcl.2019.06.041","article-title":"Sulfonamide derivatives as multi-target agents for complex diseases","volume":"29","author":"Apayd\u0131n","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115805","article-title":"Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors","volume":"261","author":"Ahmed","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0155","doi-asserted-by":"crossref","first-page":"18461","DOI":"10.1039\/D3RA03276K","article-title":"Synthesis, characterization and biological evaluation of pyrazole-based benzene sulfonamides as inhibitors of human carbonic anhydrase II","volume":"13","author":"Hussain","year":"2023","journal-title":"IX and XII, RSC Adv."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0160","article-title":"Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I","volume":"182","author":"Moi","year":"2019","journal-title":"II, IX and XII inhibitors: synthesis and biological evaluation, European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/14756366.2022.2132485","article-title":"Design and synthesis of some new benzoylthioureido benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors","volume":"38","author":"Oudah","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14756360701425014","article-title":"The role of fluorine in medicinal chemistry: review article","volume":"22","author":"Shah","year":"2007","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2000","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2014.06.074","article-title":"Synthesis of a new series of N4-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII","volume":"84","author":"S\u0142awi\u0144ski","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0185","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0190","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4412","article-title":"Crystal structure correlations with the intrinsic thermodynamics of human carbonic anhydrase inhibitor binding","volume":"6","author":"Smirnov","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0195","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1039\/D2NJ06165A","article-title":"Microwave-assisted Cu(i)-catalyzed one-pot tandem synthesis of pyridoimidazole-fused quinolines as new antimycobacterial agents: DFT and ESI-HRMS study","volume":"47","author":"Pawar","year":"2023","journal-title":"New J. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0200","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115551","article-title":"Membrane-active substituted triazines as antibacterial agents against Staphylococcus aureus with potential for low drug resistance and broad activity","volume":"258","author":"Gupta","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.135890_bb0210","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/molecules25122766","article-title":"Synthesis, antimicrobial activity and molecular docking of novel thiourea derivatives tagged with thiadiazole, imidazole and triazine moieties as potential DNA gyrase and topoisomerase IV inhibitors","volume":"25","author":"Hashem","year":"2020","journal-title":"Molecules"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024066996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024066996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T17:49:45Z","timestamp":1738777785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024066996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":42,"alternative-id":["S0141813024066996"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135890","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of 1,3,5-trisubstituted pyrazoline derivatives as human carbonic anhydrase inhibitors: Synthesis, biological evaluation and in silico studies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"135890"}}